Generics 1

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Paricalcitol manufacturers

1 products found

Filters

Filters

Filters , active

Country of origin : Netherlands

Clear all

1 products found

paricalcitol

Solution for injection 2 mcg/ml, 4 mcg/2 ml, 5 mcg/ml, 10 mcg/2 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP, FDA
Manufacturer #17457
In the past fifty years, the company has reached significant milestones—a result of enviable performance, strict adherence to the highest ethical and operational standards, and full compliance with global regulatory authorities. During this journey, they have emerged as one of the leading in-house development partners based in Europe, specializing in the development, registration, manufacturing, and life-cycle management of highly complex pharmaceutical technologies and generic formulations.

Manufacturer usually replies in 24 days

Want to see all 1 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Paricalcitol

Paricalcitol is a synthetic variety of vitamin D. Paricalcitol is used to prevent and treat secondary hyperparathyroidism associated with chronic renal failure, especially those on kidney dialysis. It is used to treat and prevent high levels of a certain natural substance called the parathyroid hormone in patients with long-term kidney disease. Parathyroid hormone controls the concentrations of calcium and phosphorus in the blood. In these patients, these low levels of calcium and a certain kind of vitamin D lead to high levels of parathyroid hormone present in the body. Higher than desirable levels of this hormone causes serious bone disorders and certain other serious health issues. Paricalcitol is used to reduce these higher than healthier levels parathyroid hormone.
Abbott Laboratories market Paricalcitol, under the trade name Zemplar.
Teva Pharmaceuticals USA currently owns the patent to Paricalcitol. However, It was patented in 1989 and approved for medical use in 1999 by the FDA, after the expiry of the initial patents other manufacturers have been assigned a different type of approvals for different preparations, however, the current patent is owned by Teva Pharma, USA.

Dosage and forms

Paricalcitol is sold as an injectable solution in 2mg and 5mg vials and capsules. The initial dosage prescribed in the treatment of Secondary Hyperparathyroidism is 0.04mg-0.1mg, 3 times a week. In patients who have already progressed to stages, 3 and 4 of chronic kidney disease, a dosage of 1 to 2mcg, up to 3 times a week is prescribed. In children age 10-16, the recommended daily dose in between 1 and 3 mcg, whereas for children younger than that, the doctor decides on the dosage.

The wholesale cost of Paricalcitol

In the USA, Paricalcitol intravenous solution (2 mcg/mL) costs around $94 for a supply of 25 ml, whereas the same quantity of medicine can cost from 60pounds per month onwards.

How does Paricalcitol work?

It is an analogue of 1,25-dihydroxyergocalciferol, the active form of vitamin D₂ and is an agonist of the vitamin D receptor which lowers parathyroid hormone levels. Vitamin D needs two sequential hydroxylations inside the liver and the kidney to bind and activate the vitamin D receptor (VDR). It works by binding to the vitamin D receptor and has been shown to reduce parathyroid hormone levels. Paricalcitol increases the expression of a tumor- suppressor gene, resulting in tumor cell suicide and tumor cell differentiation into normal its form and structure observable. Paricalcitol reduces parathyroid hormone levels and may help better absorb calcium and phosphorus.

Finding Paricalcitol manufacturers and suppliers

Paricalcitol is lifesaving drug, it is important that you are able to find the right and trusted supplier. However, given the wide range of manufacturers and suppliers this can be challenging and confusing. This can be achieved by using piplelinepharma, one of the world’s largest online B2B marketplace for drugs and pharmaceuticals. On top of the search, it also lets you finalize the deals of pharmaceutical products in a matter of a few clicks. Also, it is an easy to use online platform to grow your business opportunities.
The robust search engine makes it convenient to search for manufacturers and suppliers of Paricalcitol. The search can be further refined with industry-specific filters such as dossier type, country of origin, GMP approvals, and search criteria for Wholesaler, etc. helping to get in contact with the preferred manufacturer and supplier readily.

Interested in becoming a subscriber?

Please provide the following information to receive an offer tailored to your business needs

  1. Number of company users for the subscription
  2. The rough number of products you would like to source in the 12 months
  3. Target market(s) for commercialisation